Status: Not yet recruiting
Long-term Safety of BR005-036C Tablets in the Acute Treatment of Migraine in Adults
The purpose of this study is to evaluate the long-term safety of BR005-036C tablets in the acute treatment of migraines
Participants needed: 1,000
Trial details
Phase: Phase 3Age: 18+Biological sex: AllType: InterventionalSponsor: Brise Pharmaceuticals Co., Ltd.Updated: Sep 25, 2026Locations: 81
Eligibility criteria
Male or female Participants aged 18 years or older. [+4]
Patient with a history of or diagnosed with brainstem aura migraine, hemiplegic... [+9]